| ASSET | YEAR | % RETURN |
|---|---|---|
Alnylam Pharmaceuticals (ALNY) | 2010 | -44.73% |
Alnylam Pharmaceuticals (ALNY) | 2011 | -17.76% |
Alnylam Pharmaceuticals (ALNY) | 2012 | 119.09% |
Alnylam Pharmaceuticals (ALNY) | 2013 | 239.31% |
Alnylam Pharmaceuticals (ALNY) | 2014 | 50.97% |
Alnylam Pharmaceuticals (ALNY) | 2015 | -3.91% |
Alnylam Pharmaceuticals (ALNY) | 2016 | -59.38% |
Alnylam Pharmaceuticals (ALNY) | 2017 | 233.03% |
Alnylam Pharmaceuticals (ALNY) | 2018 | -43.18% |
Alnylam Pharmaceuticals (ALNY) | 2019 | 61.53% |
Alnylam Pharmaceuticals (ALNY) | 2020 | 12.46% |
Alnylam Pharmaceuticals (ALNY) | 2021 | 29.76% |
Alnylam Pharmaceuticals (ALNY) | 2022 | 38.93% |
Alnylam Pharmaceuticals (ALNY) | 2023 | -19.58% |
Alnylam Pharmaceuticals (ALNY) | 2024 | 23.93% |
Alnylam Pharmaceuticals (ALNY) | 2025 | 92.03% |
